Role of p53 circuitry in tumorigenesis: A brief review

被引:48
|
作者
Niazi, Sarfaraj [1 ]
Purohit, Madhusudan [1 ]
Niazi, Javed H. [2 ]
机构
[1] JSS Acad Higher Educ & Res, JSS Coll Pharm Mysuru, Dept Pharmaceut Chem, Mysuru 570015, India
[2] Sabanci Univ, SUNUM Nanotechnol Res Ctr, TR-34956 Istanbul, Turkey
关键词
p53; miRNA; Mdm2; Pirh2; COP1; Ubiquitin; Proteasome; Modulators; Pharmacophore; PROTEIN-PROTEIN INTERACTION; SMALL-MOLECULE INHIBITORS; STRUCTURE-BASED DESIGN; TUMOR-SUPPRESSOR P53; E3 UBIQUITIN LIGASE; DOUBLE MINUTE 2; MDM2-P53; INTERACTION; P53-MDM2; IN-VIVO; MUTANT P53;
D O I
10.1016/j.ejmech.2018.08.099
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Maintenance of genome integrity under the stressed condition is paramount for normal functioning of cells in the multicellular organisms. Cells are programmed to protect their genome through specialized adaptive mechanisms which will help decide their fate under stressed conditions. These mechanisms are the outcome of activation of the intricate circuitries that are regulated by the p53 master protein. In this paper, we provided a comprehensive review on p53, p53 homologues and their isoforms, including a description about the ubiquitin-proteasome system emphasizing its role in p53 regulation. p53 induced E3(Ub)-ligases are an integral part of the ubiquitin-proteasome system. This review outlines the roles of important E3(Ub)-ligases and their splice variants in maintaining cellular p53 protein homeostasis. It also covers up-to-date and relevant information on small molecule Mdm2 inhibitors originated from different organizations. The review ends with a discussion on future prospects and investigation directives for the development of next-generation modulators as p53 therapeutics. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:7 / 24
页数:18
相关论文
共 50 条
  • [1] P53 role in DNA repair and tumorigenesis
    Soddu, S
    Sacchi, A
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1997, 16 (03) : 237 - 242
  • [2] Role of Sex in the Therapeutic Targeting of p53 Circuitry
    Mancini, Francesca
    Giorgini, Ludovica
    Teveroni, Emanuela
    Pontecorvi, Alfredo
    Moretti, Fabiola
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Role of T antigen interactions with p53 in tumorigenesis
    Pipas, JM
    Levine, AJ
    SEMINARS IN CANCER BIOLOGY, 2001, 11 (01) : 23 - 30
  • [4] p53: An Attractive Therapeutic Target for Cancer
    Patel, Krupa R.
    Patel, Hitesh D.
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (22) : 3706 - 3734
  • [5] Mechanisms of p53 degradation
    Chao, Chuck C. -K.
    CLINICA CHIMICA ACTA, 2015, 438 : 139 - 147
  • [6] The p53 status can influence the role of Sam68 in tumorigenesis
    Li, Naomi
    Ngo, Chau Tuan-Anh
    Aleynikova, Olga
    Beauchemin, Nicole
    Richard, Stpehane
    ONCOTARGET, 2016, 7 (44) : 71651 - 71659
  • [7] The role of p53 tumor suppressor gene in human head and neck tumorigenesis
    Pavelic, ZP
    Gluckman, JL
    ACTA OTO-LARYNGOLOGICA, 1997, : 21 - 24
  • [8] The role of p53 in cancer drug resistance and targeted chemotherapy
    Hientz, Karin
    Mohr, Andre
    Bhakta-Guha, Dipita
    Efferth, Thomas
    ONCOTARGET, 2017, 8 (05) : 8921 - 8946
  • [9] Mutations in the p53 and SCID genes cooperate in tumorigenesis
    Nacht, M
    Strasser, A
    Chan, YR
    Harris, AW
    Schlissel, M
    Bronson, R
    Jacks, T
    GENES & DEVELOPMENT, 1996, 10 (16) : 2055 - 2066
  • [10] Stochastic modelling of tumorigenesis in p53 deficient mice
    Mao, JH
    Lindsay, KA
    Balmain, A
    Wheldon, TE
    BRITISH JOURNAL OF CANCER, 1998, 77 (02) : 243 - 252